Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-054203
Filing Date
2022-05-02
Accepted
2022-05-02 08:51:56
Documents
6
Period of Report
2022-06-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm223699-1_def14a.htm DEF 14A 742608
2 GRAPHIC lg_eyenovia-4clr.jpg GRAPHIC 53833
3 GRAPHIC tm2113618d1-icon_memberbw.jpg GRAPHIC 650
4 GRAPHIC tm2113618d1-icon_chairbw.jpg GRAPHIC 718
5 GRAPHIC tm223699d1-px_01pagebw.jpg GRAPHIC 517791
6 GRAPHIC tm223699d1-px_02pagebw.jpg GRAPHIC 618610
  Complete submission text file 0001104659-22-054203.txt   2383280
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38365 | Film No.: 22879581
SIC: 2834 Pharmaceutical Preparations